INVICTUS SECURES SUPPLY AGREEMENT WITH THE ONTARIO CANNABIS RETAIL CORPORATION
February 13 2019 - 9:01AM
INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company")
(TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce
that its wholly-owned subsidiary, Acreage Pharms Ltd. ("Acreage
Pharms"), has signed an agreement to supply the Ontario Cannabis
Retail Corporation (“OCRC”), through the Ontario Cannabis Store
(“OCS”), with a selection of premium cannabis products for the
adult recreational market.
Acreage Pharms, located in Edson, Alberta, is Invictus’ largest
purpose-built indoor facility fully licensed under the Cannabis Act
and Cannabis Regulations. The Company’s portfolio of Licensed
Producers also includes 0989561 B.C. Ltd. (“Canandia”) in Delta,
British Columbia, and AB Laboratories Inc. ("AB Labs") in Hamilton,
Ontario.
"We are thrilled to bring our premium cannabis products to
Canada’s largest market through the OCS,” said George E. Kveton,
President and CEO of Invictus. “Since the legalization of adult
recreational cannabis on October 17, 2018, we have been supplying
consumers in Alberta and BC. Now, for the first time, consumers in
Ontario will have an opportunity to experience what we have to
offer.”
Invictus’ product portfolio is expected to expand in 2019 with a
variety of new strains, oils and concentrates, as regulations
permit. In August 2018, Acreage Pharms received its extraction
license for the production of oil and is continuing to work with
Health Canada to obtain its sales license for oil products. Looking
ahead, Invictus is actively participating in consultations with the
Government of Canada on the proposed regulatory framework governing
edibles, which are expected to become legal in Canada in the fourth
quarter of 2019.
The Ontario supply agreement for adult recreational cannabis is
the Company’s fourth in Canada, following Alberta, British Columbia
and Saskatchewan. Invictus has also signed its first international
supply and distribution agreement for medical cannabis with
Deutsche Medizinalcannabis GmbH in Germany.
For more information, please visit www.invictus-md.com.
On Behalf of the Board,George E. KvetonChief Executive Officer
and Director
Jessica MartinVice President, Public Relations and Regulatory
Affairs(833) 879-4363
About Invictus
Invictus is a global cannabis company offering a selection of
products under a wide range of brands. Our integrated sales
approach is defined by five pillars of distribution including
medical, adult-use, international, Licensed Producer to Licensed
Producer and retail stores.
Invictus has partnered with business leaders to convey our
corporate vision, including KISS music legend and business mogul
Gene Simmons as our Chief Evangelist Officer. To meet growing
demand, Invictus is expanding its cultivation footprint, with three
cannabis production facilities licensed under the Cannabis Act and
Cannabis Regulations in Canada. To accommodate international sales,
Invictus’ wholly-owned subsidiary, Acreage Pharms Ltd., has
designed and is currently building its Phase 3 purpose-built
cultivation facility to be European Union Good Manufacturing
Practices compliant. The Company is targeting for up to 50 percent
of its production to comprise medical cannabis. To ensure
consistency in quality and supply, Invictus maintains all aspects
of the growing process through its subsidiary, Future Harvest
Development Ltd., a high-quality fertilizer and nutrients
manufacturer. Invictus drives sustainable long-term shareholder
value through a diversified product portfolio with over 70 Health
Canada approved strains and a multifaceted distribution strategy
including medical, adult-use, international, Licensed Producer to
Licensed Producer and retail stores. For more information visit
www.invictus-md.com.
Cautionary Note Regarding Forward-Looking Statements: This
release includes certain statements and information that may
constitute forward-looking information within the meaning of
applicable Canadian securities laws or forward-looking statements
within the meaning of the United States Private Securities
Litigation Reform Act of 1995. All statements in this news release,
other than statements of historical facts, including statements
regarding future estimates, plans, objectives, timing, assumptions
or expectations of future performance, including the sale of the
Company’s products to recreational consumers in Ontario, the
Company’s expansion of its product portfolio in 2019 and edible
cannabis anticipated to become legal in 2019 are forward-looking
statements and contain forward-looking information. Generally,
forward-looking statements and information can be identified by the
use of forward-looking terminology such as "intends" or
"anticipates", or variations of such words and phrases or
statements that certain actions, events or results "may", "could",
"should", "would" or "occur". Forward-looking statements are based
on certain material assumptions and analysis made by the Company
and the opinions and estimates of management as of the date of this
press release, including that the Company will be able to sell its
products to recreational consumers in Ontario, that the Company
will expand its product portfolio in 2019 and that the Company will
complete its launch of Invictus medical and adult recreational
brands under T2C, and edible cannabis becoming legal in 2019. These
forward-looking statements are subject to known and unknown risks,
uncertainties and other factors that may cause the actual results,
level of activity, performance or achievements of the Company to be
materially different from those expressed or implied by such
forward-looking statements or forward-looking information.
Important factors that may cause actual results to vary, include,
without limitation, that the Company will not be able to sell its
products to recreational consumers in Ontario, that the Company
will not be able to expand its product portfolio in 2019 and that
edible cannabis will not become legal in 2019. Although management
of the Company has attempted to identify important factors that
could cause actual results to differ materially from those
contained in forward-looking statements or forward-looking
information, there may be other factors that cause results not to
be as anticipated, estimated or intended. There can be no assurance
that such statements will prove to be accurate, as actual results
and future events could differ materially from those anticipated in
such statements. Accordingly, readers should not place undue
reliance on forward-looking statements and forward-looking
information. Readers are cautioned that reliance on such
information may not be appropriate for other purposes. The Company
does not undertake to update any forward-looking statement,
forward-looking information or financial out-look that are
incorporated by reference herein, except in accordance with
applicable securities laws.
Neither the TSX Venture Exchange nor its Regulation Services
Provider accepts responsibility for the adequacy or accuracy of
this release.
Jessica Martin
Invictus
(833) 879-4363
jessica@invictus-md.com
Invictus MD Strategies (TSXV:GENE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Invictus MD Strategies (TSXV:GENE)
Historical Stock Chart
From Apr 2023 to Apr 2024